dc.creator | Morillo Verdugo, Ramón Alejandro | es |
dc.creator | Lázaro López, Alicia | es |
dc.creator | Alonso Grandes, Elena | es |
dc.creator | Martín Conde, María Teresa | es |
dc.creator | Díaz Ruiz, Pilar | es |
dc.creator | Molina Cuadrado, Emilio | es |
dc.creator | Huertas Fernández, María José | es |
dc.creator | Martínez Sesmero, José Manuel | es |
dc.date.accessioned | 2023-08-01T11:10:19Z | |
dc.date.available | 2023-08-01T11:10:19Z | |
dc.date.issued | 2022 | |
dc.identifier.citation | Morillo Verdugo, R.A., Lázaro López, A., Alonso Grandes, E., Martín Conde, M.T., Díaz Ruiz, P., Molina Cuadrado, E.,...,Martínez Sesmero, J.M. (2022). Patient experience evaluation of the CMO-based pharmaceutical care model vs usual care in people living with HIV. Journal of Multidisciplinary Healthcare, 15, 2991-3003. https://doi.org/10.2147/jmdh.s392398. | |
dc.identifier.issn | 1178-2390 | es |
dc.identifier.uri | https://hdl.handle.net/11441/148348 | |
dc.description.abstract | Objective: To compare patient experience in a real-life population of people living with HIV (PLWH) who received pharmaceutical care (PC) based on the Capacity-Motivation-Opportunity (CMO) model versus the traditional model. Methods: Prospective cohort study in PLWH receiving either CMO-based PC or traditional PC in Spain between October 2019 and June 2021 (24 weeks), performed by the pharmacy department of 14 Spanish hospitals. Participants were adult patients with a clinical diagnosis of HIV treated with antiretrovirals who had been monitored in the participating hospital pharmacies for >1 year. Patient experience (IEXPAC questionnaire), clinical outcomes (cholesterol, triglycerides, HDL, glycated haemoglobin, and blood pressure), adherence to treatment, virologic control and patient satisfaction were determined. Results: Patient experience in the CMO group at week 24 was significantly better (7.6 vs 6.9) than in the traditional group, with a higher mean improvement. Adherence was better in the CMO group, particularly with regard to concomitant medications (53.2% to 91.7%, p<0.001); no changes were observed in the traditional group. Patient satisfaction improved in the CMO group vs the traditional group (48 vs 44, p[removed] | es |
dc.description.sponsorship | MSD Investigator Studies Program IIS# 56071 | es |
dc.format | application/pdf | es |
dc.format.extent | 13 | es |
dc.language.iso | eng | es |
dc.publisher | Dove Medical Press Ltd | es |
dc.relation.ispartof | Journal of Multidisciplinary Healthcare, 15, 2991-3003. | |
dc.rights | Atribución-NoComercial 4.0 Internacional | * |
dc.rights | Atribución-NoComercial 4.0 Internacional | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ | * |
dc.subject | HIV/AIDS | es |
dc.subject | Medication adherence | es |
dc.subject | Outcome assessment | es |
dc.subject | Patient satisfaction | es |
dc.subject | Pharmaceutical care | es |
dc.subject | Cholesterol | es |
dc.subject | Hemoglobin | es |
dc.subject | High density lipoprotein | es |
dc.subject | Triacylglycerol | es |
dc.subject | Antiretroviral therapy | es |
dc.subject | Blood pressure | es |
dc.subject | Capacity Motivation Opportunity model | es |
dc.subject | CD4 lymphocyte count | es |
dc.subject | Virus load | es |
dc.title | Patient experience evaluation of the CMO-based pharmaceutical care model vs usual care in people living with HIV | es |
dc.type | info:eu-repo/semantics/article | es |
dcterms.identifier | https://ror.org/03yxnpp24 | |
dc.type.version | info:eu-repo/semantics/publishedVersion | es |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | es |
dc.contributor.affiliation | Universidad de Sevilla. Departamento de Farmacología | es |
dc.relation.projectID | IIS# 56071 | es |
dc.relation.publisherversion | https://doi.org/10.2147/jmdh.s392398 | es |
dc.identifier.doi | 10.2147/jmdh.s392398 | es |
dc.journaltitle | Journal of Multidisciplinary Healthcare | es |
dc.publication.volumen | 15 | es |
dc.publication.initialPage | 2991 | es |
dc.publication.endPage | 3003 | es |
dc.contributor.funder | MSD Investigator Studies Program | es |